Ovarian stromal hyperplasia and ovarian vein steroid levels in relation to endometrioid endometrial cancer
- PMID: 12842061
Ovarian stromal hyperplasia and ovarian vein steroid levels in relation to endometrioid endometrial cancer
Abstract
Objective: To study the relationship between the presence of endometrioid endometrial cancer, the degree of ovarian stromal hyperplasia and ovarian steroid production in postmenopausal women.
Design: Retrospective and prospective study, respectively.
Setting: Medical Centre Leeuwarden and the University Hospital Groningen, The Netherlands. Postmenopausal women with or without endometrial cancer, undergoing a hysterectomy with bilateral salpingo-oophorectomy.
Methods: In 112 women with endometrioid endometrial cancer, 47 women with a benign gynaecological condition and 10 women with non-endometrioid endometrial cancer, the degree of ovarian stromal hyperplasia was scored retrospectively on a semi-quantitative scale (atrophy, slight, marked). All women were postmenopausal and had undergone a hysterectomy with bilateral salpingo-oophorectomy. Prospectively, blood sampling from the ovarian veins was performed in a further 60 women. Steroid levels (oestrone, oestradiol, androstenedione, testosterone) were determined and related to the degree of ovarian stromal hyperplasia and the presence (n = 52) or absence (n = 8) of endometrioid endometrial cancer.
Main outcome measures: Degree of ovarian stromal hyperplasia and steroid levels in the utero-ovarian circulation.
Results: In the retrospective study, the degree of ovarian stromal hyperplasia was higher in the presence of endometrioid endometrial cancer (P = 0.0001). The prospective study showed that an increasing degree of ovarian stromal hyperplasia was related to higher ovarian levels of both testosterone and androstenedione (P < 0.05 and P < 0.005, respectively), but not to oestrone or oestradiol. A non-significant increase in mean ovarian vein levels of both testosterone and androstenedione was seen in patients with endometrial cancer as compared with patients with benign conditions.
Conclusion: In endometrioid endometrial cancer, higher degrees of ovarian stromal hyperplasia were found and with increasing degrees of ovarian stromal hyperplasia, levels of ovarian vein androgens were higher. A causal relationship in the origin of hormone-dependent endometrial pathology may exist between ovarian stromal hyperplasia, ovarian vein androgen levels and endometrioid endometrial carcinoma.
Similar articles
-
Relationship between ovarian production of estrone, estradiol, testosterone, and androstenedione and the ovarian degree of stromal hyperplasia in postmenopausal women.Menopause. 1998 Winter;5(4):207-10. Menopause. 1998. PMID: 9872485
-
Quantification of Leydig cells and stromal hyperplasia in the postmenopausal ovary of women with endometrial carcinoma.Hum Pathol. 2019 Mar;85:119-127. doi: 10.1016/j.humpath.2018.10.022. Epub 2018 Nov 11. Hum Pathol. 2019. PMID: 30428390
-
Postmenopausal patients with endometrial cancer of type 1 have elevated serum estradiol levels in the ovarian vein.Int J Gynecol Cancer. 2014 Oct;24(8):1455-60. doi: 10.1097/IGC.0000000000000227. Int J Gynecol Cancer. 2014. PMID: 25078344
-
[Endometrial carcinoma and precursor lesions].Srp Arh Celok Lek. 2007 Mar-Apr;135(3-4):230-4. Srp Arh Celok Lek. 2007. PMID: 17642468 Review. Serbian.
-
Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases.Gynecol Oncol. 2004 Aug;94(2):456-62. doi: 10.1016/j.ygyno.2004.05.006. Gynecol Oncol. 2004. PMID: 15297188 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources